Category

News

Category

Does non-standardized salt form data make you shake with frustration? As much as 5% of research compounds are sold in salt form – which can have better stability, solubility, bioavailability, and manufacturability than their parent compounds. But structure and property data are not always standardized and can experimental consequences! To learn more about the importance of salt forms and how metadata could be improved in #drugdiscovery, check out our article titled ‘Addressing the challenge of…

Molport natural compound database Identifying hit and lead molecules early on in the drug development process can make all the difference between a failure and a successful campaign. Typically, this is achieved through comprehensive screening campaigns with compound libraries screened directly against a drug target, or via more complex assays such as those involving cultured cells. In either case, extensive compound libraries must be assayed against the drug target via in silico, high throughput (HTS),…

We’re so excited to introduce our uplifted brand and website: easier-to-use, simpler to navigate, and still as informative – all wrapped in a fresh new look. We hope you like it as much as we do! But if you’ve found yourself asking why and how things have changed or what this means for you – don’t worry, this blog has got you covered. Marking 15 years of simpler compound sourcing! You know us for compound…

What is changing? We’re uplifting our brand and website, making accessing the global compound marketplace easier and simpler – all wrapped in a fresh new look that reflects our leading services and cutting-edge tools. So, you can expect to see our new logo and brand colours on the website and all communications moving forward. Most importantly though, what stays the same is our commitment to making compound sourcing straight-forward, agile, and efficient. Our new website…

Latvian company, MolPort, recently celebrated its 15-year anniversary – and what a 15-years it has been! MolPort was established with a clear mission: to deliver simpler, smarter chemical compound sourcing and procurement, and in turn reduce the enormous time, cost, and effort spent by laboratories trying to find reliable suppliers. Fifteen years ago, the compound procurement landscape looked very different compared to now. It was inconvenient at best and chaotic and fraught with risk at…

The current worrying situation in Ukraine requires patience. We are looking for the best way to continue providing a great sourcing service while coping with the difficulties posed by the Russian military invasion of Ukraine. With our beliefs as a guide, we are carefully evaluating our supplier list so we only include suppliers that fully abide by global regulations and support MolPort values. We are using the following rules to evaluate the MolPort Supplier list…

Chemical procurement of a large compound library for drug screening can be a more complex task than it first appears. The process can be time-consuming, requiring the right team and expertise, defining your compound library list, and handling supplier negotiations, logistics, formatting, and budget concerns. In this overview, we take you through the chemical procurement workflow for drug screening libraries start to finish, identifying the challenges at each stage and how you can implement strategies…

Authorized customers are already taking advantage of the MolPort API to programmatically access information from the MolPort database about commercially available compounds, their suppliers, packaging, prices, warehouse inventory information, lead times, and other information. MolPort is now pleased to announce the addition of two new MolPort API calls to help customers track their compound orders: 1. List Orders This compound API call returns all orders for a specific client, and lists them in descending date…

A round-up of recent publications describing MolPort’s contributions to cutting-edge R&D projects We recently described two publications which cited the use of MolPort’s database of natural and natural-like products (a) to create a small, diverse yet representative set of available compounds, and (b) in the search for potential Covid-19 therapeutics. In this post, we are pleased to share details of other recent articles, papers, and books which discuss the use of MolPort’s range of databases and services…

What’s the most expensive available, elemental material that you can buy? No, it’s not gold: as of September 7, gold was trading at $62.32 per gram, but lutetium costs $100 per gram, and californium (which has to be made) costs $27M per gram. What about synthetic organic compounds? Surely, they can’t cost so much, can they? Well actually …. yes, they can. A quick search in MolPort’s comprehensive 7M+ database of available screening compounds and building blocks shows that the…